Bayer proposes $7.2 billion settlement to resolve weedkiller cases

Bayer has put forth a $7.2 billion settlement plan to address the multitude of lawsuits tied to its popular weedkiller Roundup, following its acquisition of Monsanto in 2018. The lawsuits have centered on claims that Roundup, which contains glyphosate, is linked to non-Hodgkin lymphoma, a type of cancer. This move comes as a response to mounting legal challenges and growing public concern over the product's safety. With this settlement, Bayer aims to bring some closure to the numerous plaintiffs while potentially avoiding the costly and time-consuming battle of fighting each case individually.